Portfolio Expansion
Expect Equity Expands Portfolio With New Stakes Across Five Companies
Anonymous
Key Points
1
Director Timothy Smokoff sold 20,000 Viemed Healthcare shares in a June 24 transaction at an average price of $11.50, totaling about $230,000, signaling insider activity around Viemed beyond the new stake disclosure.
2
NCR Voyix demonstrates deep institutional ownership, with about 97.00% of the stock currently owned by institutional investors, underscoring broad investor support even before Expect Equity’s additional stake.
3
Ascent Industries already has substantial institutional backing, with 26.05% of its stock held by hedge funds and other institutional investors, highlighting a crowded ownership landscape ahead of Expect Equity's new stake.
4
InfuSystem Holdings attracted a major new stake from BlackRock in the second quarter, with BlackRock’s purchase valued at roughly $15.3 million, signaling strong confidence from the asset manager.
5
HealthEquity shows near-total institutional ownership, with 99.55% of its stock held by institutional investors, illustrating the high level of institutional involvement around HQY.
Expect Equity LLC deployed millions across five healthcare and tech stocks in the second quarter, signaling continued institutional appetite for mid-cap companies. The fund purchased stakes in Viemed Healthcare (212,721 shares for $2.43 million), NCR Voyix (203,769 shares for $1.67 million), Ascent Industries (113,302 shares for $1.70 million), InfuSystem Holdings (184,819 shares for $1.78 million), and HealthEquity (24,200 shares for $2.19 million), according to Watchlist News. All positions represent minority stakes, ranging from roughly 0.15% to 1.6% of outstanding shares.
The purchases reflect a broader institutional shift toward niche healthcare services and health-tech segments. Each company already boasts significant institutional ownership, with HealthEquity showing 99.55% institutional stake and NCR Voyix at 97%, demonstrating deep investor confidence across the portfolio.
Viemed Healthcare Gets New Institutional Interest
Expect Equity purchased 212,721 shares of Viemed Healthcare for approximately $2.43 million in Q2, establishing a new position in the respiratory equipment provider, according to Watchlist News. The stake represents roughly 0.9% of the company's outstanding shares. Director Timothy Smokoff sold 20,000 Viemed shares on June 24 at $11.50 per share, totaling $230,000 in insider selling activity.
NCR Voyix and HealthEquity Draw Heavy Institutional Capital
NCR Voyix attracted Expect Equity's $1.67 million investment for 203,769 shares during Q2, per Watchlist News. The payments processor already has 97% institutional ownership, underscoring overwhelming investor support before this new stake. HealthEquity received 24,200 shares valued at $2.19 million, with nearly 99.55% of the stock already held by institutional investors.
BlackRock Backs InfuSystem With Major Q2 Stake
Expect Equity added 184,819 shares of InfuSystem Holdings for $1.78 million in Q2. The move coincided with BlackRock's major purchase of roughly $15.3 million worth of InfuSystem stock during the same quarter, signaling strong institutional confidence in the infusion systems provider. BlackRock's larger stake suggests growing asset manager interest in the space.
Ascent Industries Joins Crowded Institutional Ownership Landscape
Expect Equity purchased 113,302 shares of Ascent Industries for roughly $1.70 million in Q2, according to Watchlist News. Ascent already shows substantial institutional backing, with hedge funds and institutional investors controlling 26.05% of shares outstanding. The company operates in a competitive landscape with deep institutional participation ahead of this new stake.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
18
Articles
18
Reach
36
A
AnonymousAuthor
